Siemens expand its Walpole, Mass. Laboratory Diagnostic manufacturing facility
Siemens will invest $300M over the next four years
Siemens Healthineers will invest around $300 million in its Walpole, Mass. laboratory diagnostics manufacturing and research and development facility.
"The expansion of the Walpole facility fits into the strategic growth plans for the company and allows us to increase our manufacturing footprint in the United States, the largest healthcare market in the world," said Bernd Montag, Chief Executive Officer, Siemens Healthineers. "The laboratory instruments and reagents developed and manufactured at the Siemens Healthineers Walpole facility impact patients and healthcare providers across the globe. "The Walpole facility currently employs more than 700 employees and is the main manufacturing facility for assays that run on the ADVIA® Centaur family of immunoassay instruments, and for consumables for its molecular and blood gas testing instruments. The facility will also manufacture assays to run on the immunoassay module of the AtellicaTM Solution, which is currently in development. R&D efforts at the site bring new tests to the diagnostics market to help physicians diagnose and treat disease.
"With a 37-year history of manufacturing products in Walpole, we saw an opportunity to leverage the local talent in the community to further our growth and expansion plans," said Franz Walt, President, Laboratory Diagnostics, Siemens Healthineers.
The company plans to upgrade and expand its existing 500,000 sq. ft. complex. Renovations to the existing facility will begin in the coming weeks. The expansion—which will include manufacturing, warehouse, office and lab space—is set to begin in the summer. Siemens Healthineers is committed to creating at least 400 positions. The company anticipates that it may ultimately create up to as many as 700 new permanent jobs to bring the total employment at the site to between 1,300 and 1,600 by 2026. These employees will join the 46,000 Siemens Healthineers around the world who enable healthcare providers to deliver excellent patient care.
Other news from the department business & finance
These products might interest you
Mars 6 by CEM
Everything under Control - with This Intelligent Microwave Digestion System
High Sample Throughput with Just One Click
HYDROTHERM by C. Gerhardt
Efficiency in food analysis: Safe and precise total fat determination made easy
Fully automatic acid hydrolysis in 90 minutes - validated for continuous operation
VICI DBS ZeroAir by VICI
Generate up to 30 L/min of analytically pure air yourself – for stable baseline GC-FID applications
Increase the sensitivity of your GC-FID analysis while reducing costs
CrystalBreeder by Technobis
CrystalBreeder: the next generation multi-reactor crystallization platform
Enhance your early stage solid state screening. New: controlled evaporation & vapor diffusion modes
APU sim by Analytik Jena
APU sim Automatic Preparation Unit
APU sim The Clever Sample Preparation System According to Column Method
OHAUS Laboratory equipment by Ohaus
Do More with OHAUS Laboratory Equipment
Do Not Limit Yourself to Just Measurement! Discover Ingenious Portfolio
Automatische XPR-Waagen by Mettler-Toledo
Production of standards, samples and concentrations - fast and reliable
Automate the weighing processes in your laboratory - ideal also for sample prep at chromatography
FlowSyn and FlowSyn Maxi by Uniqsis
Continuous Flow Chemistry Systems for reaction optimisation and scale up
Perform reactions up to 300°C and 100 bar from 0.1 - 100 ml /minute
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
